THE LATEST ARTICLES
NEWSLETTERS
therapy mental health
Ian Krietzberg September 30, 2025
A newish startup hopes to leverage generative A.I. to treat millions of people with cognitive issues. But like most shiny new industry objects, the next step is gathering robust evidence to prove that the system actually works.
Sam Altman
Ian Krietzberg September 25, 2025
Sam Altman’s company, which is valued at half a trillion dollars, will earn around $13 billion in revenue this year and likely burn through $100 billion by the end of the decade. Here’s why that makes sense, at least according to Global X’s Tejas Dessai.
clinical drug trial breast cancer detection
Ian Krietzberg September 23, 2025
Investors are shoveling hundreds of millions of dollars into the quixotic promise of A.I.-assisted drug discovery, but a handful of tech companies are pursuing a parallel, potentially more impactful endeavor: leveraging artificial intelligence to speed up enormously costly, time-consuming clinical trials.
Mark Kelly
Ian Krietzberg September 18, 2025
In a candid conversation, astronaut turned senator Mark Kelly discusses his new A.I. policy road map, how the private sector can help “win” the A.I. arms race, and whether going all in on the technology is wise to begin with.


chatbot ai school aducation
Ian Krietzberg September 16, 2025
News and notes on Aloe, a buzzy new entrant in the A.I. race, which is seemingly capable of building, vetting, and using tools to more reliably answer user queries.
school computer ai
Ian Krietzberg September 11, 2025
A bracing roundtable with professors and academics about how A.I. has invaded their classrooms, whether it’s incompatible with the aims of higher education, and their recently published open letter calling on universities to reject the use of generative A.I. in schools.
Sam Altman
Ian Krietzberg September 9, 2025
The latest lawsuit over a chatbot-fueled tragedy raises novel questions for OpenAI and the artificial intelligence industry: Would a “reasonable person” rely upon ChatGPT for important life decisions? And does a lack of reasonable safeguards amount to negligence?
HER movie
Ian Krietzberg September 4, 2025
Slingshot, which counts a16z as an investor, recently launched “Ash,” a new therapy chatbot that’s being billed as a cheap pocket shrink. Is this an improvement on the current anthropomorphizing of ChatGPT, a preview of the inevitable, or just a really bad idea?


waiter robot ai job
Ian Krietzberg September 2, 2025
Another new academic paper adds some nuance to the dystopian narrative that A.I. is coming for all of our jobs. As usual, the truth is more complex and, frankly, uncertain.
Tye Sheridan Nikola Todorovic
Ian Krietzberg August 28, 2025
Amid all the hyperventilating and legitimate fears over generative A.I., a new wave of entrepreneurs is creating more specialized, A.I.-fueled VFX tools to empower directors, lower effects budgets, and maybe even help the industry embrace its future.
1 2 3 4 5 6